ASCO Guidelines

164 Jaksot

1. Management of Metastatic Renal Clear Cell Cancer Rapid Recommendation Update

   Julkaistiin: 10.10.2023
2. Systemic Therapy for Tumor Control in Metastatic Well-Differentiated GEP-NETs Guideline

   Julkaistiin: 29.9.2023
3. Systemic Therapy for Melanoma Guideline Update

   Julkaistiin: 6.9.2023
4. Integrative Oncology Care of Symptoms of Anxiety and Depression in Adults with Cancer: SIO-ASCO Guideline

   Julkaistiin: 15.8.2023
5. Management of Stage III NSCLC Rapid Recommendation Update

   Julkaistiin: 20.7.2023
6. Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy Guideline Update

   Julkaistiin: 17.7.2023
7. Cancer Cachexia Rapid Recommendation Update

   Julkaistiin: 12.7.2023
8. Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2023.2

   Julkaistiin: 11.7.2023
9. HER2 Testing in Breast Cancer: ASCO-CAP Guideline Update

   Julkaistiin: 7.6.2023
10. Testing for ESR1 Mutations to Guide Therapy for HR-Positive, HER2-Negative Metastatic Breast Cancer Rapid Recommendation Update

    Julkaistiin: 17.5.2023
11. VTE Prophylaxis and Treatment in Patients with Cancer Guideline Update

    Julkaistiin: 19.4.2023
12. Management of Anxiety and Depression in Adult Survivors of Cancer Guideline Update

    Julkaistiin: 19.4.2023
13. Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2023.1 Part 2

    Julkaistiin: 6.4.2023
14. Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2023.1 Part 1

    Julkaistiin: 6.4.2023
15. Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer Guideline Update

    Julkaistiin: 3.4.2023
16. Penile Cancer: EAU-ASCO Guideline

    Julkaistiin: 10.3.2023
17. Chemotherapy and Targeted Therapy for Endocrine-Pretreated or Hormone Receptor–Negative Metastatic Breast Cancer Rapid Recommendation Update

    Julkaistiin: 20.1.2023
18. Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: ASCO Endorsement of CAP Guideline

    Julkaistiin: 6.1.2023
19. Targeted Therapy and Immunotherapy for Gastroesophageal Cancer Guideline

    Julkaistiin: 5.1.2023
20. Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2022.2 Part 2

    Julkaistiin: 19.12.2022